Obama Prioritizes Personalized Medicine

The President is launching a new initiative to help researchers and clinicians fully realize the dream of “precision medicine.”

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

JANE ADES, NHGRI Science advocates certainly took note of President Barack Obama’s overtures to the American research enterprise in his recent State of the Union address. In particular, Obama’s brief announcement regarding what he called “precision medicine”—more commonly referred to as personalized medicine—piqued the community’s interest. “Tonight, I’m launching a new precision medicine initiative to bring us closer to curing diseases like cancer and diabetes—and to give all of us access to the personalized information we need to keep ourselves and our families healthier,” Obama said during last week’s address.

“As I was watching [the address] I was delighted,” Richard Weinshilboum, acting director of the Mayo Clinic Center for Individualized Medicine in Rochester, Minnesota, told US News & World Report. “The timing is excellent.”

According to The New York Times (NYT), Obama’s initiative will be fleshed out more thoroughly when he presents his budget to Congress in the coming weeks. And the measure, for which Obama may request hundreds of millions of dollars, will likely have friends on both sides of the political aisle. “This is an incredible area of promise,” Senator Bill Cassidy (R-LA), told the NYT. “There will be bipartisan support.”

Advances in genomics have helped make personalized medicine a clinical reality in scattered instances, and several patients have benefitted from the tailor-made ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies